ovalo health bpc 157 BPC-157 Healthletic BPC 157 | SuppCo

We continue to believe this regulation would provide the additional context needed for consumers of the MRFs to create meaningful dollar comparisons that would ultimately benefit consumers through development of cost comparison tools, increased competition, or improved price negotiations with employers

doi:10.2147/RRU.S143679

WADA's rationale is that BPC-157 is a pharmacological substance not approved for human therapeutic use by any regulatory authority, and its tissue repair properties could provide a performance-enhancing benefit

what about if the pt came in for Prolieve (CPT 53850) that has a 90 day global period, who also received a gentamicin injection (96372 w/ J1580) at the time of the procedure